Literature DB >> 21923991

Characteristics and management of adnexal masses in a canadian pediatric and adolescent population.

Yolanda A Kirkham1, Judith A Lacy, Sari Kives, Lisa Allen.   

Abstract

OBJECTIVE: To determine whether there were differences in presentation, imaging, and tumour markers between pediatric and adolescent gynaecology patients with adnexal masses managed expectantly and those managed surgically.
METHODS: We conducted a retrospective review of patients who presented to the pediatric and adolescent gynaecology service with adnexal masses between January 2003 and January 2006 at Toronto's Hospital for Sick Children. We used t tests, chi-square, and Pearson correlation tests for analysis.
RESULTS: We identified 114 patients with an adnexal mass. Fifty-nine percent had surgery (laparotomy 41.8%, laparoscopy 58.2%) and 41% were managed conservatively. The mean age of patients was 12.7 years (range 7 days to 18 years) and there was no difference in age between management groups (P = 0.59). The most common presenting symptom was abdominal pain (72.8%). Increased abdominal girth was found only in the surgical group (P < 0.01). Size of the mass was the only feature on imaging that differed between groups (11.1 cm surgical vs. 5.3 cm observed, P < 0.001). CT scans were performed in 35 patients, 94.3% of whom had surgery (P < 0.001). Tumour markers were drawn in 41.2% of patients, more often in surgical patients (P < 0.001), and 27% were abnormal, all in the surgical group. Surgical approaches included cystectomy, oophorectomy, or detorsion. Twelve percent of surgeries were for malignancies, representing 7.0% of all adnexal masses, and malignant masses were larger than benign masses (16.1 cm vs. 10.5 cm, P < 0.05). In cases that required only expectant management with serial ultrasound, both simple and complex masses resolved, with or without hormonal suppression.
CONCLUSION: Larger masses and masses associated with increased abdominal girth or abnormal tumour markers were more likely to be managed by surgical intervention. Surgically managed patients had more investigations. Forty-one percent of masses in patients referred to pediatric and adolescent gynaecology specialists resolved with expectant management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923991     DOI: 10.1016/s1701-2163(16)35019-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  7 in total

Review 1.  Magnetic resonance imaging of pediatric adnexal masses and mimics.

Authors:  Christopher Z Lam; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2018-08-04

2.  A Giant Ovarian Cystadenoma in A 20-Year-Old Nulliparous Woman: A Case Report.

Authors:  Cipta Pramana; Lulu Almarjan; Pramadio Mahaputera; Satrio Adi Wicaksono; Giri Respati; Firdaus Wahyudi; Cahyono Hadi
Journal:  Front Surg       Date:  2022-05-05

3.  The Influence of Living in Rural Areas on the Evolution and Management of Pediatric Ovarian Cystic Lesions: A Retrospective Study on a Cohort from South Eastern Romania.

Authors:  Ioana Anca Stefanopol; Magdalena Miulescu; Luiza Nechita; Ciprian Adrian Dinu; Carmen Bobeica; Alexandru Nechifor; Liliana Baroiu; Sergiu Chirila; Lucreţia Anghel; Victorita Stefanescu; Alin Laurenţiu Tatu
Journal:  Int J Gen Med       Date:  2022-05-27

4.  Simulated impact of pelvic MRI in treatment planning for pediatric adnexal masses.

Authors:  Alessandro Marro; Lisa M Allen; Sari L Kives; Rahim Moineddin; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2016-04-20

5.  Selecting treatment method for ovarian masses in children - 24 years of experience.

Authors:  Justyna Łuczak; Maciej Bagłaj
Journal:  J Ovarian Res       Date:  2017-09-11       Impact factor: 4.234

Review 6.  A review of ovary torsion.

Authors:  Ci Huang; Mun-Kun Hong; Dah-Ching Ding
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Jul-Sep

7.  MR imaging in discriminating between benign and malignant paediatric ovarian masses: a systematic review.

Authors:  Lotte W E van Nimwegen; Annelies M C Mavinkurve-Groothuis; Ronald R de Krijger; Caroline C C Hulsker; Angelique J Goverde; József Zsiros; Annemieke S Littooij
Journal:  Eur Radiol       Date:  2019-09-16       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.